404 Not Found

Not Found

The requested URL /output was not found on this server.

Welcome to Biolauncher - where science and technology businesses succeed

+44 (0)1865 575 170
Rowan Gardner

Rowan Gardner

Chairman

+44 (0)1865 575170

Chairman

  • Commercial Strategy85%
  • Venture Investing78%
  • Investment Readiness83%
Rowan is an Oxford trained Biochemist with considerable commercial experience and a global network

Rowan Gardner is a life science strategy and business development professional with a substantial network of investor contacts that participate in all stages of company creation and growth. As Head of Investor Relations at Oxford Molecular she developed and delivered the corporate communications, IR and PR strategies.

Rowan maintains close relationships with various industry groups such as Astia, and Digital Health Forum. She has consulted to various UK RDAs, SMEs and financial institutions to help broker, fund and develop new initiatives. Rowan has recently led projects to bring new venture and translational capital into the UK life sciences sector.


Steve Gardner

Steve Gardner

Chief Technology Officer

+44 (0)1865 575170

Chief Technical Officer

  • Business Planning93%
  • Large scale data analytics90%
  • Grant Applications85%
Steve is a serial entrepreneur and an acknowledged visionary in the field of large scale informatics in life sciences

Dr Steve Gardner has over 20 years of experience and a strong track record of building world-class companies, teams and products within the life science and healthcare industries. He specializes in designing and delivering advanced semantic integration and search systems and has raised over £50M, participated in an LSE flotation and 11 corporate acquisitions. In his role as CTO of BioWisdom he worked on over 25 safety, regulatory and marketing projects for major pharmaceutical companies and provided the informatics support to the InnoMed (Alzheimer’s biomarkers) project for the EU under the FP6 programme. Steve was a lead contributor to the €2B EU IMI programme’s Strategic Research Agenda. Steve was founder and CEO of Synomics Ltd and European MD and CTO for Viaken Systems. Prior to that, Steve was Worldwide Director of Research Informatics for Astra AB, and as Senior Product Manager at Oxford Molecular, he co‐ordinated the senior scientific advisory meetings including four Nobel Laureates..